Burning Rock Biotech Statistics
Share Statistics
Burning Rock Biotech has 1.08M
shares outstanding. The number of shares has increased by 0.14%
in one year.
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | 0.14% |
| Shares Change (QoQ) | 2.94% |
| Owned by Institutions (%) | 0.21% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 98 |
| FTD / Avg. Volume | 0.3% |
Short Selling Information
The latest short interest is 38.22K, so 0.37% of the outstanding
shares have been sold short.
| Short Interest | 38.22K |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.52% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1.47 and the forward
PE ratio is null.
Burning Rock Biotech's PEG ratio is
0.
| PE Ratio | -1.47 |
| Forward PE | n/a |
| PS Ratio | 0.99 |
| Forward PS | 0 |
| PB Ratio | 0.88 |
| P/FCF Ratio | -5.18 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Burning Rock Biotech.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92,
with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.92 |
| Quick Ratio | 2.71 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | -0.19 |
| Debt / FCF | -0.53 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $765,314.54 |
| Profits Per Employee | $-514,281.9 |
| Employee Count | 674 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.85 |
Taxes
| Income Tax | 5.88M |
| Effective Tax Rate | -1.73% |
Stock Price Statistics
The stock price has increased by -56.92% in the
last 52 weeks. The beta is 0.72, so Burning Rock Biotech's
price volatility has been higher than the market average.
| Beta | 0.72 |
| 52-Week Price Change | -56.92% |
| 50-Day Moving Average | 3.33 |
| 200-Day Moving Average | 4.8 |
| Relative Strength Index (RSI) | 51.73 |
| Average Volume (20 Days) | 32,379 |
Income Statement
In the last 12 months, Burning Rock Biotech had revenue of 515.82M
and earned -346.63M
in profits. Earnings per share was -335.6.
| Revenue | 515.82M |
| Gross Profit | 362.4M |
| Operating Income | -357.56M |
| Net Income | -346.63M |
| EBITDA | -270.23M |
| EBIT | -322.43M |
| Earnings Per Share (EPS) | -335.6 |
Full Income StatementBalance Sheet
The company has 519.85M in cash and 52.32M in
debt, giving a net cash position of 467.53M.
| Cash & Cash Equivalents | 519.85M |
| Total Debt | 52.32M |
| Net Cash | 467.53M |
| Retained Earnings | -4.2B |
| Total Assets | 885.3M |
| Working Capital | 510.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -92.26M
and capital expenditures -5.98M, giving a free cash flow of -98.24M.
| Operating Cash Flow | -92.26M |
| Capital Expenditures | -5.98M |
| Free Cash Flow | -98.24M |
| FCF Per Share | -0.95 |
Full Cash Flow StatementMargins
Gross margin is 70.26%, with operating and profit margins of -69.32% and -67.2%.
| Gross Margin | 70.26% |
| Operating Margin | -69.32% |
| Pretax Margin | -66.06% |
| Profit Margin | -67.2% |
| EBITDA Margin | -52.39% |
| EBIT Margin | -69.32% |
| FCF Margin | -19.04% |
